Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesis.
R. Elias Alvarado, Jennifer Chen, Kumari G. Lokugamage, Yiyang Zhou, Leah K. Estes, Angelica L. Morgan, Yani P. Ahearn, Xiangxue Deng, Lilin Lai, Arian Moayyed, William M. Meyers, Jessica A. Plante, Kenneth S. Plante, David Hughes Walker, Xuping Xie, , Vineet D. Menachery
This study shows that disrupting both NSP3 and nucleocapsid SG antagonism reduces SARS-CoV-2 replication and disease, suggesting stress granule activation as a therapeutic target.
bioRxiv · Jun 18, 2026 · PreprintMicrobiology